Health Canada has
released its findings from a detailed review of public consultations on the potential prescription-free therapeutic uses of cannabis for pain relief and other ailments.
The findings, which centred mainly on whether or not CBD should be allowed to be sold by retailers without strict regulations, has revealed that nearly two-thirds of the 1,104 respondents polled are interested in buying "cannabis health products," with the majority of consumers interested in using the products to treat pain and inflammation.
The respondents also suggested CBD should not be regulated the same way as THC-based, adult-use cannabis products. Health Canada said it plans to create a scientific advisory committee later this year to seek external advice that will support developing standards for the sale of products containing cannabis “without doctors’ or regulatory oversight.”
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.